|
2859
|
J147
|
Potent and orally active neurotrophic drug |
€90.00 |
|
1843
|
JAK2 inhibitor 13
|
JAK2 inhibitor |
€105.00 |
|
3002
|
JH-RE-06
|
Specific and in vivo active REV1-REV7 interaction inhibitor |
Recently added
|
€145.00 |
|
2160
|
JIB 04
|
Jumonji histone demethylase inhibitor |
€90.00 |
|
2654
|
JK184
|
Hedgehog (Hh) signaling pathway antagonist with antiproliferative activity |
€80.00 |
|
1307
|
JNJ 10191584
|
H4 antagonist |
€80.00 |
|
2529
|
JNJ 26481585 dihydrochloride
|
Potent, orally available second-generation pan-HDAC inhibitor |
€125.00 |
|
1538
|
JNJ 26854165
|
HDM2 inhibitor |
€105.00 |
|
1586
|
JNJ 26854165 dihydrochloride
|
HDM2 inhibitor |
€105.00 |
|
1802
|
JNJ 37822681 dihydrochloride
|
D2 antagonist |
€135.00 |
|
2890
|
JNJ 47965567
|
Potent, brain-penetrant P2X7 antagonist |
€135.00 |
|
2793
|
JNJ 55511118
|
Negative modulator of AMPA receptor (TARP-γ8 selective) |
€95.00 |
|
2569
|
JNJ 63533054
|
Potent, brain-penetrant, selective agonist of GPR139 |
€90.00 |
|
1306
|
JNJ 7777120
|
H4 antagonist |
€80.00 |
|
2949
|
JNK inhibitor VIII
|
Selective, ATP-competitive, and cell-permeable JNK inhibitor |
€105.00 |